DIN 02518058 — BREZTRI AEROSPHERE 7.2 MCG; 5 MCG; 160 MCG
BREZTRI AEROSPHERE is a aerosol (metered-dose) of Budesonide / Glycopyrronium / Formoterol Fumarate marketed by ASTRAZENECA CANADA INC. The full Budesonide / Glycopyrronium / Formoterol Fumarate monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02518058
- Brand name
- BREZTRI AEROSPHERE
- Active ingredient
- Budesonide / Glycopyrronium / Formoterol Fumarate
- Strength
- 7.2 MCG; 5 MCG; 160 MCG
- Dosage form
- AEROSOL (METERED-DOSE)
- Route
- INHALATION
- Manufacturer
- ASTRAZENECA CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Inhaled corticosteroid (ICS) / long-acting muscarinic antagonist (LAMA) / long-acting beta2-adrenergic agonist (LABA) triple combination
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.